Removal of heparin from heparin-containing blood plasma samples using a triethylaminoethyl cellulose tablet
AssigneeWarner-Lambert Company
InventorsJames R. Butler, James E. Turner, Frank W. Goodhart
Life of this patent
Estimating the term…
Loading patent…
AssigneeWarner-Lambert Company
InventorsJames R. Butler, James E. Turner, Frank W. Goodhart
Estimating the term…
A tableted form of fibrous triethylaminoethyl cellulose suitable for the removal of heparin from heparin-containing blood plasma. The tablet is composed of granular microcrystalline cellulose and fibrous triethylaminoethyl cellulose in a ratio of from about 5.4:1 to about 10:1. The triethylaminoethyl cellulose tablet, which is formulated to provide from about 5 to about 26 mg. of triethylaminoethyl cellulose per milliliter of plasma sample, is added to a heparin-containing blood plasma sample, the sample is agitated or allowed to stand for a time sufficient to permit adsorption of substantially all heparin present. The sample is then centrifuged and the remaining heparin-free plasma can be subjected to coagulation testing in order to determine the true clotting time.
A method for removing substantially all heparin from a heparin-containing blood plasma test sample which comprises:
Dependencies are inferred from the claim text.